Immutep IMMP
NASDAQ IMMP
$4.56 -0.09 (-1.82%)
As of: Oct 1, 2026 · 11:23 AM EDT

Immutep (IMMP) Asset Utilization Ratio (2017)

Updated

Immutep's (IMMP) Asset Utilization Ratio stood at 0.13 in the year ended Jun 30, 2026, up 128.2% from 0.06 a year earlier.

Analysis

Immutep (IMMP) Asset Utilization Ratio (2017) Analysis & Trends

Starting with the year ended Jun 30, 2012, Immutep's Asset Utilization Ratio history includes 10 years.

  • The figure for the year ended Jun 30, 2026 is the highest annual Asset Utilization Ratio since the year ended Jun 30, 2022.
  • Per Business Quant data, IMMP's Asset Utilization Ratio was 0.06 in the year ended Jun 30, 2025 and 1789.97 in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.49
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.47
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.52
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.44
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.53
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.40
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.58
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 0.47
10 Immutep 33.95 Mn 33.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 0.08
API Access

Immutep Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=IMMP&period=max&api_key=YOUR_API_KEY